发明名称 USE OF A2B ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING HEART FAILURE AND ARRHYTHMIA IN POST-MYOCARDIAL INFARCTION PATIENTS
摘要 Provided are methods of improving the cardiac condition of post-myocardial infarction (MI) patients and reducing cardiovascular death and hospitalization due to heart failure or arrhythmias, by administering a therapeutically effective amount of an A 2B adenosine receptor antagonist.
申请公布号 EP3103454(A1) 申请公布日期 2016.12.14
申请号 EP20160180014 申请日期 2012.04.05
申请人 Gilead Sciences, Inc. 发明人 BELARDINELLI, Luiz;ZHONG, Hongyan;ZENG, Dewan
分类号 A61K31/522;A61K9/00;A61K9/02;A61K31/40;A61K31/403;A61K45/06;A61K47/06;A61P9/00;A61P9/04;A61P9/10 主分类号 A61K31/522
代理机构 代理人
主权项
地址